FierceBiotech 2025-12-04 GE HealthCare, Mayo Clinic launch digital twin project for personalizing radiation cancer therapy
FierceBiotech 2025-12-04 Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
FierceBiotech 2025-12-04 After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
FierceBiotech 2025-12-04 Crescent waxes pipeline with $80M Kelun deal, bagging ADC to pair with PD-1xVEGF bispecific
FierceBiotech 2025-12-04 Royalty pens $275M financing deal for Denali drug awaiting delayed FDA decision
FierceBiotech 2025-12-04 After more than 20 years, Medtronic claims deep brain stimulation approval for dystonia
FierceBiotech 2025-12-04 A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes
FierceBiotech 2025-12-04 FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center
FierceBiotech 2025-12-04 FDA floats user fee cuts for early-stage US trials, additional fees for overseas development
FierceBiotech 2025-12-03 Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy
FierceBiotech 2025-12-03 Fierce Biotech Fundraising Tracker '25: Triana glues $120M series B; Protego raises $130M
FierceBiotech 2025-12-03 With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis
FierceBiotech 2025-12-03 Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
FierceBiotech 2025-12-02 Janux T-cell engager data sink stock, but analysts still see best-in-class potential
FierceBiotech 2025-12-02 Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter